focus -WSS

focus

author：leisure time 2025-09-30 20:46:53 - browse：9

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： JPM: CVS says Medicare Advantage patients are impacting profits

hotspot

WSS

2 US Navy sailors arrested for allegedly spying for China

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

3 medical device trends to watch in 2024

Morgan Health, with ambitious aims, wants you to know it’s still here

Chronically ill young patients struggle to find fertility info

OTC birth control: A brief history of over the counter pill design

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Medical leaders decry Supreme Court decision on affirmative action

Chronically ill young patients struggle to find fertility info

Medicare proposal to cover medical devices draws a mixed reaction

The FDA must approve intranasal treatments for anaphylaxis

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Ancient DNA,' 23andMe reveal African American ancestries

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Malaria cases in Florida and Texas: Here’s what you need to know

Verily hires former Apple Health leader as chief scientific officer

explore

Ahead of JPM, here's who's profiting most in health care

A cyberattack has disrupted hospitals and health care in several states

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

2 US Navy sailors arrested for allegedly spying for China

Dramatically reducing cancer deaths requires the PASTEUR Act

My superpower is killing ticks

hotspot

focus

knowledge

focus